A defining 2026 shift in the Japanese market is the emergence of Autologous Stem Cell Cultivation as a high-tier alternative to traditional transplants. In 2026, Japan’s world-leading regenerative medicine laws have allowed clinics in Tokyo and Osaka to offer "pure stem cell" courses, where a patient’s own cells are multiplied in a lab and re-injected into the scalp. This 2026...